Table 3.
PID | Sample Collected # days Prior to Positive 3rd Generation Rapid Test |
HIV-1 RNA (Copies/mL) |
Rapid Test | Immunoassay | Confirmatory Tests | ||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
CE-Marked HIV Combo |
Determine™ HIV-1/2 Ag/ Ab Combo |
GS HIV- 1/2 + O |
GS HIV Combo Ag/Ab |
Multispot HIV- 1/HIV-2 |
GS HIV-1 Western Blot (bands) | Geenius HIV-1/2 Supplemental (bands) |
|||
1 | 27 | 1,904,350 | Ag/Ab | Ab | R | R | NR | Ind. (gp41, p24) | HIV Neg. |
2 | 28 | 1,554,640 | Ag/Ab | Ab | NR | R | NR | Ind. (gp41) | HIV Neg. |
3 | 29 | 4,790,990 | Ag | Ag | NR | R | NR | Ind. (p55/51, gp41) | HIV-2 Ind. (gp140) |
4 | 32 | 17,546,710 | Ag | Ag | NR | R | NR | Neg. | HIV Neg. |
5 | 12 | 65,672,120 | Ag | Neg. | NR | R | NR | Neg. | HIV Neg. |
6 | 20 | 2,176,510 | Ag | Neg. | NR | R | NR | Ind. (*gp41, *p18) | HIV Neg. |
7 | 23 | 18,683,070 | Ag/Ab | Neg. | R | R | HIV-1 R | Neg. | HIV Neg. |
8 | 29 | 6,373,520 | Ag/Ab | Neg. | R | R | NR | Neg. | HIV Neg. |
9 | 30 | 20,594,620 | Ag/Ab | Neg. | NR | R | NR | Neg. | HIV Neg. |
10 | 30 | 3,426,650 | Ag | Neg. | NR | R | NR | Ind. (gp41) | HIV Neg. |
11 | 32 | 2660 | Ag | Neg. | NR | NR | NR | Ind. (*gp41, p55/51) | HIV-2 Ind. (gp140) |
12 | 35 | 2,180,160 | Ag | Neg. | R | R | NR | Ind. (*gp41) | HIV Neg. |
13 | 52 | 154 | Ab | Neg. | R | R | NR | Ind. (*p55/51, *p41, p40, p24) | HIV Neg. |
14 | 56 | 3,405,070 | Ag | Neg. | NR | R | NR | Ind. (*gp41) | HIV Neg. |
15 | 57 | 533,140 | Ag | Neg. | NR | R | NR | Neg. | HIV Neg. |
16 | 82 | 12,706,620 | Ag/Ab | Neg. | NR | R | NR | Neg. | HIV Neg. |
Abbreviations: Participant identifier (PID); Antigen (Ag); Antibody (Ab); Antigen/Antibody (Ag/Ab); Negative (Neg.); Reactive (R); Non-Reactive (NR); Indeterminate (Ind.).